LENSAR, Inc. (LNSR) Social Stream



LENSAR, Inc. (LNSR): $3.76

0.22 (+6.21%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

LENSAR INC (LNSR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering LNSR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 2 $20 $20 $20 $4.43 351.47%
2021-11-22 2 $20 $15 $17.5 $4.43 295.03%
2022-05-09 2 $15 $12 $13.5 $4.43 204.74%
NA 1 $NA $NA $NA $4.43 NA%

The Trend in the Analyst Price Target


LNSR's average price target has moved down $6.5 over the prior 40 weeks.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

LNSR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 120 days, LNSR's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LNSR as an investment opportunity.

  • LNSR has a higher number of analysts covering the stock than 8.46% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, LENSAR INC's variance in analysts' estimates is lower than 66.22% of them.
  • LENSAR INC's upside potential (average analyst target price relative to current price) is greater than 411.55% of Medical Equipment stocks.
  • LENSAR INC's average analyst price target is higher than 112.1% of Medical Equipment stocks.

Stocks similar to LENSAR INC in the Medical Equipment industry regarding analyst recommendations and price targets are VVOS, ICU, and FEMY.

What is the outlook for LNSR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!